The FDA recently approved Pfizer Animal Health’s new veterinary fluroquinolone, Zeniquin® (marbofloxacin). This drug joins three other veterinary approved fluoroquinolones already on the market, Baytrillv® (enrofloxacin), Orbae (orbifloxacin), and Dicural® (difloxacin). Zeniquin® is approved for dogs only with a dose range of 1.25 to 2.5 mg/pound PO once daily. The most common adverse drug reactions observed during clinical trials were decreased activity, loss of appetite, and vomiting.
The nutraceutical chromium picolinate is sometimes used as a supplement in obese cats with newly diagnosed Type 2 diabetes mellitus to improve glucose metabolism and enhance insulin sensitivity. The feline dose is 200 micrograms per cat daily.
(1) Journal of the American Veterinary Medicine Association, vol 215, No. 2, July 15, 1999, pp 161-183.
(2) Plumb, Donald C. Veterinary Drug Handbook, 3rd ed. Ames: Iowa State University Press, 1999.
(3) Federal Register, April 9. 1999